Despite our initial findings that knockdown of VGF significantly inhibited the growth of UM cells, whereas its impact on nontumor cells was comparatively limited, more evidence is needed to comprehensively evaluate the safety and efficacy of VGF inhibition in the treatment of malignant tumors in the future. The gene discussed is VGF; the disease is cancer.